Fred’s experience in advising companies during the start up, growth, and maturity phases of their corporate life cycles is illustrated by his work in the following transactions:
TECHNOLOGY MEDIA & COMMUNICATIONS (TMC) - ( link for LIFE SCIENCES )
- Spin-out of Autonomy Corporation plc from Cambridge Neurodynamics Limited (“CNL”). Fred acted for Apax on their original investment into CNL in the early 1990’s. Since then, he has advised CNL’s founder, Dr Mike Lynch, in connection with Autonomy from its spin-out, through it’s IPO and subsequent listings (see “Growth” below).
- The Cambridge Network Limited. This is Cambridge’s principal corporate networking organisation. Fred was one of the original six co-founders.
- Unipalm Pipex Limited Fred advised Peter Dawe the founder from the start up of Pipex, through it’s IPO and eventual trade sale (see ”Maturity” below). These transactions were a landmark for the UK Technology sector in the mid 1990s, and as a result have been incorporated as business school case studies.
- 3Way Networks. Fred was the Non-Executive Director representing the Cambridge Angel investors until 3Way’s sale to Airvana Inc
- Point 35 Microstructures. Fred is a Non-Executive Director and has advised the founding management team during the development and launch of their revolutionary MEMSSTAR product and organised the £2.1m A Round financing.
- Elonics. Fred is the Non-Executive Director advising the founding CEO during the development and launch of Elonics’ new wireless silicon products, and organised the £2M A Round financing.
- Xaar plc pre-IPO private placing.
- Autonomy Corporation pre IPO grooming (see ”Start-Up” above).
- Johnston Press plc £560m acquisition of RIM and related £220m rights issue.
- Forth Dimension Displays. Fred became Non Executive Chairman in 2007 following a restructuring.
- SMG £216m sale of publishing division.
- Xaar plc IPO on LSE.
- Unipalm Pipex £20m IPO on LSE and subsequent £95m sale to Metropolitan Fibre Systems (see ”Start- Up” above).
- Autonomy Corporation IPO on EASDAQ, listing on NASDAQ and FTSE100 introduction to LSE (See “Start-Up” above).
- Orbital Software IPO on LSE and sale to Sopheon.
- LifeScan (formerly Inverness Medical Limited). Fred was involved with Inverness Medical from its start up through to its sale to Johnson & Johnson.
- Quadrant Technologies - Fred raised the initial start-up funding. Quadrant was acquired in 2005 by Innovata plc (See ‘Maturity, Innovata plc’ below.)
- Inveresk Research $79m MBO from SGI.
- Inveresk Research $115m acquisition of Clintrials.
- Inveresk Research $450m IPO on NASDAQ and subsequent $230m placing, and $ 1,400m merger with Charles River Laboratories.
- Innovata. £128m sale of Innovata to Vectura